Eftychia Lekka

Publications

• Molecular basis of mood and cognitive adverse events elucidated via a combination of pharmacovigilance data mining and functional enrichment analysis
• Topiramate protects apoE-deficient mice from kidney damage without affecting plasma lipids
• Drug repurposing of Pirlindole for Multiple Sclerosis
• Association of Microbiome Organisms to Regulatory T Cell function in Cancer and Inflammation
• Literature analysis for systematic drug repurposing: a case study from Biovista
• NK Cell Adoptive Transfer Combined with Ontak-Mediated Regulatory T Cell Elimination Induces Effective Adaptive Antitumor Immune Responses
• Abstract P2-20-03: Combination Immunotherapy for Breast Cancer Patients: Safety and Immunologic Data from a Phase II Trial Administering a HER2/neu-Derived Peptide vaccine (AE37+GM-CSF) Sequentially or Concurrently with Trastuzumab in the Adjuvant Setting
• Identification and characterization of a HER-2/neu epitope as a potential target for cancer immunotherapy.
• Peptide vaccination breaks tolerance to HER-2/neu by generating vaccine-specific FasL(+) CD4(+) T cells: first evidence for intratumor apoptotic regulatory T cells.
• Identification of a novel immunogenic HLA-A*0201-binding epitope of HER-2/neu with potent antitumor properties.
• Building an Adverse Outcome Pathway network for COVID-19
• Why adverse outcome pathways need to be FAIR
• Methods2AOP: An International Collaboration Advancing AOP Key Event Descriptions
• GABAA receptor-mediated seizure liabilities: a mixed-methods screening approach
• IND02-05 The NeuroDeRisk toolbox: DeRisking chemical structures for neurotoxic adverse outcomes
• Rupatadine Treatment Is Associated with Atherosclerosis Worsening and Altered T Lymphocyte Recruitment
• Association of microbiome organisms to Regulatory T Cell function in cancer and inflammation.